Topical Fluorometholone Protects the Ocular Surface of Dry Eye Patients from Desiccating Stress

Three-week topical 0.1% fluorometholone therapy is effective not only in reducing ocular surface signs in DED patients, but also especially in preventing exacerbation caused by exposure to a desiccating stress.